Cyclin D2 Antikörper (AA 190-289)
-
- Target Alle Cyclin D2 (CCND2) Antikörper anzeigen
- Cyclin D2 (CCND2)
-
Bindungsspezifität
- AA 190-289
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Cyclin D2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant CCND2.
- Sequenz
- TDFKFAMYPP SMIATGSVGA AICGLQQDEE VSSLTCDALT ELLAKITNTD VDCLKACQEQ IEAVLLNSLQ QYRQDQRDGS KSEDELDQAS TPTDVRDIDL
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- CCND2 (AAH10958, 190 a.a. ~ 289 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 3B10
- Isotyp
- IgG1
- Top Product
- Discover our top product CCND2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
- Target
- Cyclin D2 (CCND2)
- Andere Bezeichnung
- CCND2 (CCND2 Produkte)
- Synonyme
- si:ch211-240j22.2 antikoerper, ccnd2 antikoerper, CCND2 antikoerper, kiak0002 antikoerper, zgc:162280 antikoerper, LOC100224096 antikoerper, KIAK0002 antikoerper, BF642806 antikoerper, C86853 antikoerper, Vin-1 antikoerper, Vin1 antikoerper, cD2 antikoerper, 2600016F06Rik antikoerper, AI256817 antikoerper, cyclin D2, b antikoerper, cyclin D2 S homeolog antikoerper, cyclin D2 antikoerper, G1/S-specific cyclin-D2 antikoerper, cyclin D2, a antikoerper, cyclin D2 L homeolog antikoerper, ccnd2b antikoerper, ccnd2.S antikoerper, CCND2 antikoerper, ccnd2 antikoerper, ccnd2a antikoerper, Ccnd2 antikoerper, ccnd2.L antikoerper
- Hintergrund
-
Full Gene Name: cyclin D2
Synonyms: KIAK0002,MGC102758 - Gen-ID
- 894
- Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
-